Guo Rui Ruan (Guo-Rui Ruan, GuoRui Ruan, Guorui Ruan)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Multiple Myeloma

Top Venues

British journal of haematology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ya-Lan Zhou, Ming-Yue Zhao, Robert Peter Gale, Hao Jiang, Qian Jiang, Li-Xia Liu, Jia-Yue Qin, Shan-Bo Cao, Feng Lou, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo Rui Ruan
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia (2023)
Xin'an Pan, Yingjun Chang, Guo Rui Ruan, Fangfang Wei, Hao Jiang, Qian Jiang, Xiaojun Huang, Xiao-Jun Huang
Prognostic impact of FLT3-ITD mutation on NPM1 + acute myeloid leukaemia patients and related molecular mechanisms. British journal of haematology (2023)
Jing Wang, Hao Jiang, Yu Jing, Long Su, Daihong Liu, Daobin Zhou, Jingbo Wang, Hui Liu, Guo Rui Ruan, Sujun Gao, Xiao Jun Huang
Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA. British journal of haematology 198 (1) (2022)
Jing Wang, RunQing Lu, Ying Wu, JinSong Jia, Lizhong Gong, XiaoHong Liu, ShengYe Lu, Yu Wang, ChenHua Yan, Xin-Xin Liu, Xiao-Hui Zhang, Lan-Ping Xu, Qian Jiang, XiaoSu Zhao, HongXia Shi, YueYun Lai, XiaoJun Huang, Guo Rui Ruan, Hao Jiang
Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA. British journal of haematology 190 (4) (2020)
Zi-Long Wang, Yang Liu, Ya-Lan Zhou, Jin-Lan Li, Qiu-Yu Sun, Li-Xin Wu, Lei Wen, Yue-Yun Lai, Yan-Rong Liu, Ying-Jun Chang, Hong-Xia Shi, Xin-Xin Liu, Xiao-Jun Huang, Jin Lu, Guo Rui Ruan
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma. European journal of haematology 105 (2) (2020)
Jia-Min Zhang, Yan Xu, Robert P Gale, Li-Xin Wu, Jing Zhang, Yong-Huai Feng, Ya-Zhen Qin, Hao Jiang, Qian Jiang, Bin Jiang, Yan-Rong Liu, Yu-Hong Chen, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Xiao-Jun Huang, Xin-Xin Liu, Guo Rui Ruan
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia. British journal of haematology 190 (1) (2020)
Ya-Lan Zhou, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, Bin Jiang, Shan-Bo Cao, Feng Lou, Ying Sun, Cheng-Cheng Wang, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xin-Xin Liu, Guo Rui Ruan, Xiao-Jun Huang
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD). British journal of haematology 190 (2) (2020)